Philipp Y. Maximov

1.0k total citations
26 papers, 760 citations indexed

About

Philipp Y. Maximov is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Philipp Y. Maximov has authored 26 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Philipp Y. Maximov's work include Estrogen and related hormone effects (23 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Computational Drug Discovery Methods (5 papers). Philipp Y. Maximov is often cited by papers focused on Estrogen and related hormone effects (23 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Computational Drug Discovery Methods (5 papers). Philipp Y. Maximov collaborates with scholars based in United States, Romania and United Kingdom. Philipp Y. Maximov's co-authors include V. Craig Jordan, Theresa M. Lee, Ramona Curpăn, Russell E. McDaniel, Ping Fan, Joan Lewis-Wambi, V. Craig Jordan, Elizabeth E. Sweeney, Cynthia B. Myers and Fadeke A. Agboke and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Philipp Y. Maximov

25 papers receiving 743 citations

Peers

Philipp Y. Maximov

GENET

ONCOL

CTM

Joan S. Lewis United States

Luciana F. Macedo United States

Irida Kastrati United States

Joan Lewis-Wambi United States

Steven Sugarman United States

Joanna M. Day United Kingdom

Xiaoguo H. Zhan United States

Catherine G.N. Sharma United States

Y. Nishino Germany

Long G. Wang United States

Joan S. Lewis United States

Philipp Y. Maximov

400 ×1.0

GENET

338 ×1.2

243 ×1.2

ONCOL

45 ×0.4

35 ×0.4

CTM

Citations per year, relative to Philipp Y. Maximov Philipp Y. Maximov (= 1×) peers Joan S. Lewis

Countries citing papers authored by Philipp Y. Maximov

Since Specialization

Citations

This map shows the geographic impact of Philipp Y. Maximov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Y. Maximov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Y. Maximov more than expected).

Fields of papers citing papers by Philipp Y. Maximov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Y. Maximov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Y. Maximov. The network helps show where Philipp Y. Maximov may publish in the future.

Co-authorship network of co-authors of Philipp Y. Maximov

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Y. Maximov. A scholar is included among the top collaborators of Philipp Y. Maximov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Y. Maximov. Philipp Y. Maximov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Алашеев, А. М., et al.. (2025). Lack of interactions of SERMs with Asp351 and Phe404 of the oestrogen receptor alpha correlates with endometrial cancer development in patients. Molecular Simulation. 51(5). 311–327.

Maximov, Philipp Y., et al.. (2022). Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer. Frontiers in Endocrinology. 13. 869562–869562. 5 indexed citations

Maximov, Philipp Y., Ramona Curpăn, Sean W. Fanning, et al.. (2020). Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Molecular Cancer Therapeutics. 20(1). 11–25. 9 indexed citations

Volpato, Milène, Michele Cummings, Abeer M. Shaaban, et al.. (2020). Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer. SHILAP Revista de lepidopterología. 1(5). 355–371. 6 indexed citations

Maximov, Philipp Y., Ramona Curpăn, Ping Fan, et al.. (2020). Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer. Molecular Pharmacology. 98(4). 364–381. 16 indexed citations

Maximov, Philipp Y., Yousef M. Hawsawi, Yue Chen, et al.. (2020). The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Molecular Pharmacology. 98(1). 24–37. 18 indexed citations

Maximov, Philipp Y., Sean W. Fanning, Surojeet Sengupta, et al.. (2018). Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Molecular Pharmacology. 94(2). 812–822. 28 indexed citations

Maximov, Philipp Y., et al.. (2017). A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. Endocrine Related Cancer. 25(2). R83–R113. 19 indexed citations

Jordan, V. Craig, et al.. (2016). Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.. PubMed. 21(117). 411–27. 17 indexed citations

10.

Fan, Ping, Heather E. Cunliffe, Philipp Y. Maximov, et al.. (2015). Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells. Molecular Cancer Research. 13(10). 1367–1376. 27 indexed citations

11.

Jordan, V. Craig, Ramona Curpăn, & Philipp Y. Maximov. (2015). Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators. JNCI Journal of the National Cancer Institute. 107(6). djv075–djv075. 34 indexed citations

12.

Fan, Ping, et al.. (2015). The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. Molecular and Cellular Endocrinology. 418. 245–263. 24 indexed citations

13.

White, Bethany E. Perez, Rui Xiong, Hitisha Patel, et al.. (2014). Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer. Molecular Cancer Therapeutics. 13(11). 2515–2526. 16 indexed citations

14.

Jordan, V. Craig, Russell E. McDaniel, Fadeke A. Agboke, & Philipp Y. Maximov. (2014). The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators. Steroids. 90. 3–12. 24 indexed citations

15.

Maximov, Philipp Y., et al.. (2014). Pharmacological Relevance of Endoxifen in a Laboratory Simulation of Breast Cancer in Postmenopausal Patients. JNCI Journal of the National Cancer Institute. 106(10). 15 indexed citations

16.

Maximov, Philipp Y., Russell E. McDaniel, Valeriy R. Korostyshevskiy, et al.. (2014). Simulation with cellsin vitroof tamoxifen treatment in premenopausal breast cancer patients with differentCYP2D6 genotypes. British Journal of Pharmacology. 171(24). 5624–5635. 25 indexed citations

17.

McDaniel, Russell E., Philipp Y. Maximov, & V. Craig Jordan. (2013). Estrogen-Mediated Mechanisms to Control the Growth and Apoptosis of Breast Cancer Cells. Vitamins and hormones. 93. 1–49. 10 indexed citations

18.

Maximov, Philipp Y., Theresa M. Lee, & V. Craig Jordan. (2013). The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice. Current Clinical Pharmacology. 8(2). 135–155. 282 indexed citations

19.

Sweeney, Elizabeth E., Russell E. McDaniel, Philipp Y. Maximov, Ping Fan, & V. Craig Jordan. (2012). Models and mechanisms of acquired antihormone resistance in breast cancer: significant clinical progress despite limitations. Hormone Molecular Biology and Clinical Investigation. 9(2). 143–163. 70 indexed citations

20.

Maximov, Philipp Y., Surojeet Sengupta, Joan Lewis-Wambi, et al.. (2011). The conformation of the estrogen receptor directs estrogen-induced apoptosis in breast cancer: a hypothesis. Hormone Molecular Biology and Clinical Investigation. 5(1). 27–34. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact